Lu Zhong-Jie, Yu Qi, Zhou Shui-Hong, Fan Jun, Shen Li-Fang, Bao Yang-Yang, Wu Ting-Ting, Zhou Min-Li, Huang Ya-Ping
Department of Radiotherapy.
Department of Otolaryngology,
Cancer Manag Res. 2019 Mar 8;11:2087-2096. doi: 10.2147/CMAR.S183859. eCollection 2019.
Glucose transporter (GLUT)-mediated glucose uptake is an important process in the development of laryngeal carcinoma, one of the most common malignancies of the head and neck. GLUT-1, together with HIF-1α, is also an indicator of hypoxia. Both proteins play a critical role in glucose uptake and glycolysis in laryngeal carcinoma cells under hypoxic stress. A double gene knockout model in which and are no longer expressed can provide important information about carcinogenesis in laryngeal carcinoma.
In this study we used the CRISPR/Cas 9 system to induce HIF-1α and GLUT-1 double gene knockout in HEp-2 cells and then used the knocked-out cells to study the role of these markers in laryngeal carcinoma, including in chemoradioresistance.
High-grade small-guide RNAs (sgRNAs) of HIF-1α and GLUT-1 were designed using an online tool and inserted into the pUC57-T7-gRNA vector. The recombinant plasmids were transfected into HEp-2 cells and positive cells were screened using the dilution method. Gene mutation and expression were determined by sequence analysis and immunoblotting.
In HIF-1α and GLUT-1 double gene knockout HEp-2 cells, a 171-bp deletion in the genomic sequence was detected, whereas multiple base insertions resulted in frameshift mutations in the gene. Neither HIF-1α nor GLUT-1 protein was expressed in positive cells. The proliferation, migration, and invasion of HEp-2 cells were significantly decreased afterward. The possible mechanism may be that the inhibition PI3K/AKT/mTOR pathway by HIF-1α and double gene knockout using CRISPR/Cas9 technique lead to reduction of glucose uptake and lactic acid generation.
Our and double gene knockout HEp-2 cell model, obtained using a CRISPR/Cas9-based system, may facilitate studies of the pathogenesis of laryngeal carcinoma.
葡萄糖转运蛋白(GLUT)介导的葡萄糖摄取是喉癌发生发展过程中的一个重要过程,喉癌是头颈部最常见的恶性肿瘤之一。GLUT-1与缺氧诱导因子-1α(HIF-1α)一样,也是缺氧的一个指标。这两种蛋白在缺氧应激下的喉癌细胞的葡萄糖摄取和糖酵解过程中都起着关键作用。一种 和 不再表达的双基因敲除模型可以为喉癌的致癌机制提供重要信息。
在本研究中,我们使用CRISPR/Cas 9系统在HEp-2细胞中诱导HIF-1α和GLUT-1双基因敲除,然后利用敲除后的细胞研究这些标志物在喉癌中的作用,包括在放化疗抵抗中的作用。
使用在线工具设计HIF-1α和GLUT-1的高级小向导RNA(sgRNAs),并将其插入pUC57-T7-gRNA载体。将重组质粒转染到HEp-2细胞中,并使用稀释法筛选阳性细胞。通过序列分析和免疫印迹法测定基因突变和表达情况。
在HIF-1α和GLUT-1双基因敲除的HEp-2细胞中,检测到 基因组序列中有171个碱基对的缺失,而多个碱基插入导致 基因发生移码突变。在阳性细胞中,HIF-1α和GLUT-1蛋白均未表达。此后,HEp-2细胞的增殖、迁移和侵袭能力均显著降低。可能的机制是,利用CRISPR/Cas9技术敲除HIF-1α和 双基因导致PI3K/AKT/mTOR通路受到抑制,从而导致葡萄糖摄取和乳酸生成减少。
我们使用基于CRISPR/Cas9的系统获得的 和 双基因敲除HEp-2细胞模型,可能有助于喉癌发病机制的研究。